XML 42 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed consolidating financial statements
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed consolidating financial statements Condensed consolidating financial statements
The following information is presented in accordance with Rule 3-10 of Regulation S-X. The operating and investing activities of the separate legal entities included in the Company’s condensed consolidated financial statements are fully interdependent and integrated. Revenues and operating expenses of the separate legal entities include intercompany charges for management and other administrative services. The Company’s senior notes are guaranteed by a substantial majority of its domestic subsidiaries as measured by revenue, income and assets. The subsidiary guarantors have guaranteed the senior notes on a joint and several basis. However, a subsidiary guarantor will be released from its obligations under its guarantee of the senior notes and the indentures governing the senior notes if, in general, there is a sale or other disposition of all or substantially all of the assets of such subsidiary guarantor, including by merger or consolidation, or a sale or other disposition of all of the equity interests in such subsidiary guarantor held by the Company and its restricted subsidiaries, as defined in the indentures; such subsidiary guarantor is designated by the Company as an unrestricted subsidiary, as defined in the indentures, or otherwise ceases to be a restricted subsidiary of the Company, in each case in accordance with the indentures; or such subsidiary guarantor no longer guarantees any other indebtedness, as defined in the indentures, of the Company or any of its restricted subsidiaries, except for guarantees that are contemporaneously released. The senior notes are not guaranteed by certain of the Company’s domestic subsidiaries, any of the Company’s foreign subsidiaries, or any entities that do not constitute subsidiaries within the meaning of the indentures, such as corporations in which the Company holds capital stock with less than a majority of the voting power, joint ventures and partnerships in which the Company holds less than a majority of the equity or voting interests, non-owned entities and third parties.
Condensed Consolidating Statements of Operations
 
 
 
DaVita Inc.
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
For the three months ended March 31, 2019
 
 
 
 
 
Patient services revenues
 
$

 
$
1,777,246

 
$
918,604

 
$
(60,698
)
 
$
2,635,152

Provision for uncollectible accounts
 

 
(3,970
)
 
(1,493
)
 

 
(5,463
)
Net patient service revenues
 

 
1,773,276

 
917,111

 
(60,698
)
 
2,629,689

Other revenues
 
188,836

 
111,141

 
35,619

 
(222,173
)
 
113,423

Total net revenues
 
188,836

 
1,884,417

 
952,730

 
(282,871
)
 
2,743,112

Operating expenses and charges
 
143,659

 
1,660,453

 
881,364

 
(282,871
)
 
2,402,605

Operating income
 
45,177

 
223,964

 
71,366

 

 
340,507

Debt expense
 
(133,595
)
 
(52,479
)
 
(10,719
)
 
65,274

 
(131,519
)
Other income, net
 
110,198

 
2,596

 
9,111

 
(114,965
)
 
6,940

Income tax expense
 
7,026

 
46,544

 
3,176

 

 
56,746

Equity earnings in subsidiaries
 
134,535

 
46,151

 

 
(180,686
)
 

Net income from continuing operations
 
149,289

 
173,688

 
66,582

 
(230,377
)
 
159,182

Net (loss) income from discontinued operations, net of tax
 

 
(39,153
)
 
19,767

 
49,691

 
30,305

Net income
 
149,289

 
134,535

 
86,349

 
(180,686
)
 
189,487

Less: Net income attributable to noncontrolling interests
 

 

 

 
(40,198
)
 
(40,198
)
Net income attributable to DaVita Inc.
 
$
149,289

 
$
134,535

 
$
86,349

 
$
(220,884
)
 
$
149,289


 
 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
For the three months ended March 31, 2018
 
DaVita Inc.
 
 
 
 
Patient service revenues
 
$

 
$
1,790,188

 
$
848,401

 
$
(47,515
)
 
$
2,591,074

Provision for uncollectible accounts
 

 
9,628

 
15,917

 

 
25,545

Net patient service revenues
 

 
1,799,816

 
864,318

 
(47,515
)
 
2,616,619

Other revenues
 
195,565

 
204,960

 
70,933

 
(238,633
)
 
232,825

Total net revenues
 
195,565

 
2,004,776

 
935,251

 
(286,148
)
 
2,849,444

Operating expenses
 
133,356

 
1,791,094

 
800,456

 
(286,148
)
 
2,438,758

Operating income
 
62,209

 
213,682

 
134,795

 

 
410,686

Debt expense
 
(114,334
)
 
(52,197
)
 
(7,375
)
 
60,390

 
(113,516
)
Other income
 
104,081

 
2,523

 
5,704

 
(107,726
)
 
4,582

Income tax expense
 
14,387

 
48,944

 
7,406

 

 
70,737

Equity earnings in subsidiaries
 
141,117

 
66,496

 

 
(207,613
)
 

Net income from continuing operations
 
178,686

 
181,560

 
125,718

 
(254,949
)
 
231,015

Net loss from discontinued operations, net of tax
 

 
(40,443
)
 
(12,679
)
 
47,336

 
(5,786
)
Net income
 
178,686

 
141,117

 
113,039

 
(207,613
)
 
225,229

Less: Net income attributable to noncontrolling interests
 

 

 

 
(46,543
)
 
(46,543
)
Net income attributable to DaVita Inc.
 
$
178,686

 
$
141,117

 
$
113,039

 
$
(254,156
)
 
$
178,686



Condensed Consolidating Statements of Comprehensive Income
 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
For the three months ended March 31, 2019
 
DaVita Inc.
 
 
 
 
Net income
 
$
149,289

 
$
134,535

 
$
86,349

 
$
(180,686
)
 
$
189,487

Other comprehensive income (loss)
 
1,026

 

 
(13,653
)
 

 
(12,627
)
Total comprehensive income
 
150,315

 
134,535

 
72,696

 
(180,686
)
 
176,860

Less: Comprehensive income attributable to noncontrolling interest
 

 

 

 
(40,198
)
 
(40,198
)
Comprehensive income attributable to DaVita Inc.
 
$
150,315

 
$
134,535

 
$
72,696

 
$
(220,884
)
 
$
136,662

 
 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
For the three months ended March 31, 2018
 
DaVita Inc.
 
 
 
 
Net income
 
$
178,686

 
$
141,117

 
$
113,039

 
$
(207,613
)
 
$
225,229

Other comprehensive income
 
2,587

 

 
19,881

 

 
22,468

Total comprehensive income
 
181,273

 
141,117

 
132,920

 
(207,613
)
 
247,697

Less: Comprehensive income attributable to noncontrolling interest
 

 

 

 
(46,543
)
 
(46,543
)
Comprehensive income attributable to DaVita Inc.
 
$
181,273

 
$
141,117

 
$
132,920

 
$
(254,156
)
 
$
201,154


Condensed Consolidating Balance Sheets
 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
As of March 31, 2019
 
DaVita Inc.
 
 
 
 
Cash and cash equivalents
 
$
194,347

 
$

 
$
264,895

 
$

 
$
459,242

Restricted cash and equivalents
 
1,006

 
12,114

 
89,072

 

 
102,192

Accounts receivable, net
 

 
1,349,185

 
604,237

 

 
1,953,422

Other current assets
 
37,185

 
568,029

 
100,058

 

 
705,272

Current assets held for sale, net
 

 
4,842,062

 
1,162,886

 

 
6,004,948

Total current assets
 
232,538

 
6,771,390

 
2,221,148

 

 
9,225,076

Property and equipment, net
 
503,677

 
1,610,442

 
1,278,147

 

 
3,392,266

Operating lease right-of-use assets
 
107,237

 
1,594,411

 
1,034,888

 

 
2,736,536

Intangible assets, net
 
130

 
39,813

 
78,381

 

 
118,324

Investments in subsidiaries
 
10,191,084

 
3,323,518

 

 
(13,514,602
)
 

Intercompany receivables
 
3,756,675

 

 
1,496,009

 
(5,252,684
)
 

Other long-term assets and investments
 
53,978

 
84,137

 
196,259

 

 
334,374

Goodwill
 

 
4,812,366

 
1,987,002

 

 
6,799,368

Total assets
 
$
14,845,319

 
$
18,236,077

 
$
8,291,834

 
$
(18,767,286
)
 
$
22,605,944

Current liabilities
 
$
4,702,717

 
$
1,182,342

 
$
592,508

 
$

 
$
6,477,567

Current liabilities held for sale
 

 
1,084,512

 
668,798

 

 
1,753,310

Intercompany payables
 

 
3,648,453

 
1,604,231

 
(5,252,684
)
 

Long-term operating leases liabilities
 
133,936

 
1,502,922

 
988,918

 

 
2,625,776

Long-term debt and other long-term liabilities
 
5,520,830

 
626,764

 
371,980

 

 
6,519,574

Noncontrolling interests subject to put provisions
 
612,482

 

 

 
530,562

 
1,143,044

Total DaVita Inc. shareholders' equity
 
3,875,354

 
10,191,084

 
3,323,518

 
(13,514,602
)
 
3,875,354

Noncontrolling interests not subject to put
provisions
 

 

 
741,881

 
(530,562
)
 
211,319

Total equity
 
3,875,354

 
10,191,084

 
4,065,399

 
(14,045,164
)
 
4,086,673

Total liabilities and equity
 
$
14,845,319

 
$
18,236,077

 
$
8,291,834

 
$
(18,767,286
)
 
$
22,605,944


 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
As of December 31, 2018
 
DaVita Inc.
 
 
 
 
Cash and cash equivalents
 
$
60,653

 
$

 
$
262,385

 
$

 
$
323,038

Restricted cash and equivalents
 
1,005

 
12,048

 
79,329

 

 
92,382

Accounts receivable, net
 

 
1,264,290

 
594,318

 

 
1,858,608

Other current assets
 
37,185

 
601,318

 
122,063

 

 
760,566

Current assets held for sale
 

 
4,440,953

 
948,612

 

 
5,389,565

Total current assets
 
98,843

 
6,318,609

 
2,006,707

 

 
8,424,159

Property and equipment, net
 
491,462

 
1,624,835

 
1,277,372

 

 
3,393,669

Intangible assets, net
 
153

 
42,933

 
75,760

 

 
118,846

Investments in subsidiaries
 
10,102,750

 
3,239,862

 

 
(13,342,612
)
 

Intercompany receivables
 
3,419,448

 

 
1,471,203

 
(4,890,651
)
 

Other long-term assets and investments
 
53,385

 
80,537

 
197,696

 

 
331,618

Goodwill
 

 
4,812,365

 
2,029,595

 

 
6,841,960

Total assets
 
$
14,166,041

 
$
16,119,141

 
$
7,058,333

 
$
(18,233,263
)
 
$
19,110,252

Current liabilities
 
$
1,945,943

 
$
1,251,534

 
$
449,925

 
$

 
$
3,647,402

Current liabilities held for sale
 

 
722,766

 
520,993

 

 
1,243,759

Intercompany payables
 

 
3,327,026

 
1,563,625

 
(4,890,651
)
 

Long-term debt and other long-term liabilities
 
7,918,581

 
715,065

 
552,406

 

 
9,186,052

Noncontrolling interests subject to put provisions
 
598,075

 

 

 
526,566

 
1,124,641

Total DaVita Inc. shareholders' equity
 
3,703,442

 
10,102,750

 
3,239,862

 
(13,342,612
)
 
3,703,442

Noncontrolling interests not subject to put
provisions
 

 

 
731,522

 
(526,566
)
 
204,956

Total equity
 
3,703,442

 
10,102,750

 
3,971,384

 
(13,869,178
)
 
3,908,398

Total liabilities and equity
 
$
14,166,041

 
$
16,119,141

 
$
7,058,333

 
$
(18,233,263
)
 
$
19,110,252

 
 
Condensed Consolidating Statements of Cash Flows
 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
For the three months ended March 31, 2019
 
DaVita Inc.
 
 
 
 
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net income
 
$
149,289

 
$
134,535

 
$
86,349

 
$
(180,686
)
 
$
189,487

Changes in operating assets and liabilities and non-cash
items included in net income
 
(124,409
)
 
(197,096
)
 
92,636

 
180,686

 
(48,183
)
Net cash provided by (used in) operating activities
 
24,880

 
(62,561
)
 
178,985

 

 
141,304

Cash flows from investing activities:
 
 

 
 

 
 

 
 

 
 

Additions of property and equipment
 
(38,942
)
 
(112,376
)
 
(47,560
)
 

 
(198,878
)
Acquisitions
 

 

 
(11,274
)
 

 
(11,274
)
Proceeds from asset and business sales
 

 
1,456

 
12,447

 

 
13,903

Proceeds (purchases) from investment sales and other items, net
 
1,804

 
(4,558
)
 
(1,355
)
 

 
(4,109
)
Net cash used in investing activities
 
(37,138
)
 
(115,478
)
 
(47,742
)
 

 
(200,358
)
Cash flows from financing activities:
 
 

 
 

 
 

 
 

 
 

Long-term debt and related financing costs, net
 
365,133

 
(2,439
)
 
(5,497
)
 

 
357,197

Intercompany borrowing (payments)
 
(220,697
)
 
229,211

 
(8,514
)
 

 

Other items
 
1,517

 
(8,480
)
 
(25,283
)
 

 
(32,246
)
Net cash provided by (used in) financing activities
 
145,953

 
218,292

 
(39,294
)
 

 
324,951

Effect of exchange rate changes on cash, cash
equivalents and restricted cash
 

 

 
(921
)
 

 
(921
)
Net increase in cash, cash equivalents and
restricted cash
 
133,695

 
40,253

 
91,028

 

 
264,976

Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations
 

 
40,187

 
78,775

 

 
118,962

Net increase in cash, cash equivalents and restricted cash from continuing operations
 
133,695

 
66

 
12,253

 

 
146,014

Cash, cash equivalents and restricted cash of continuing
operations at beginning of the year
 
61,658

 
12,048

 
341,714

 

 
415,420

Cash, cash equivalents and restricted cash of continuing
operations at end of the period
 
$
195,353

 
$
12,114

 
$
353,967

 
$

 
$
561,434


 
 
 
 
 
Guarantor
subsidiaries
 
Non-
Guarantor
subsidiaries
 
Consolidating
adjustments
 
Consolidated
total
For the three months ended March 31, 2018
 
DaVita Inc.
 
 
 
 
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net income
 
$
178,686

 
$
141,117

 
$
113,039

 
$
(207,613
)
 
$
225,229

Changes in operating assets and liabilities and non-cash
items included in net income
 
(82,391
)
 
32,484

 
(20,396
)
 
207,613

 
137,310

Net cash provided by operating activities
 
96,295

 
173,601

 
92,643

 

 
362,539

Cash flows from investing activities:
 
 

 
 

 
 

 
 

 
 

Additions of property and equipment
 
(27,356
)
 
(125,375
)
 
(79,712
)
 

 
(232,443
)
Acquisitions
 

 
(4,417
)
 
(12,165
)
 

 
(16,582
)
Proceeds from asset and business sales
 

 
18,535

 

 

 
18,535

Proceeds (purchases) from investment sales and other items, net
 
31,665

 
(762
)
 
(541
)
 

 
30,362

Net cash provided by (used in) investing activities
 
4,309

 
(112,019
)
 
(92,418
)
 

 
(200,128
)
Cash flows from financing activities:
 
 

 
 

 
 

 
 

 
 

Long-term debt and related financing costs, net
 
116,307

 
(3,377
)
 
(8,257
)
 

 
104,673

Intercompany borrowing (payments)
 
47,394

 
(49,783
)
 
2,389

 

 

Other items
 
(291,562
)
 
(2,200
)
 
(33,458
)
 

 
(327,220
)
Net cash used in financing activities
 
(127,861
)
 
(55,360
)
 
(39,326
)
 

 
(222,547
)
Effect of exchange rate changes on cash, cash
equivalents and restricted cash
 

 

 
6,668

 

 
6,668

Net decrease in cash, cash equivalents and restricted cash
 
(27,257
)
 
6,222

 
(32,433
)
 

 
(53,468
)
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations
 

 
6,185

 
11,649

 

 
17,834

Net (decrease) increase in cash, cash equivalents and restricted cash from continuing operations
 
(27,257
)
 
37

 
(44,082
)
 

 
(71,302
)
Cash, cash equivalents and restricted cash of continuing
operations at beginning of the year
 
150,307

 
9,384

 
359,229

 

 
518,920

Cash, cash equivalents and restricted cash of continuing
operations at end of the period
 
$
123,050

 
$
9,421

 
$
315,147

 
$

 
$
447,618